Detalhe da pesquisa
1.
Practical use of insulin degludec/insulin aspart in a multinational setting: beyond the guidelines.
Diabetes Obes Metab
; 22(11): 1961-1975, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32618405
2.
Clinical and Economic Assessment of MyDiaCare, Digital Tools Combined With Diabetes Nurse Educator Support, for Managing Diabetes in South Africa: Observational Multicenter, Retrospective Study Associated With a Budget Impact Model.
JMIR Form Res
; 7: e35790, 2023 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37548994
3.
Prevalence and risk factors of vascular complications in type 2 diabetes mellitus: Results from discover Middle East and Africa cohort.
Front Endocrinol (Lausanne)
; 13: 940309, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36017310
4.
Characteristics and Treatment Patterns of Patients with Type 2 Diabetes Mellitus in the Middle East and Africa Cohort of the DISCOVER Study Program: a Prospective Study.
Diabetes Ther
; 13(7): 1339-1352, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35689732
5.
Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries.
Adv Ther
; 39(8): 3735-3748, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35752730
6.
A comprehensive overview of pneumococcal vaccination recommendations for adults in South Africa, 2022.
J Thorac Dis
; 14(10): 4150-4172, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36389298
7.
ARISE-a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in real-world settings: rationale and design.
Endocrine
; 74(3): 530-537, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34637072
8.
Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial.
Lancet Diabetes Endocrinol
; 7(8): 596-605, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31189519
9.
Correction to: Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries.
Adv Ther
; 40(1): 389-390, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36315342
10.
Correction: ARISE-a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in realworld settings: rationale and design.
Endocrine
; 75(3): 964, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34919203
11.
Incretins: cardiovascular safety and rationale for use.
Cardiovasc J Afr
; 24(2): 46, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23750348